91ÑÇÉ«´«Ã½

Lipid News

Dysregulation of a lipid transfer protein linked to brain disorders

Kentaro Hanada
By Kentaro Hanada
April 12, 2022

Advanced studies of human genetics are a big wave in the medical sciences. Collaborative teams of clinical geneticists and bioinformaticians are surfing this wave, rapidly discovering genomic variations associated with specific human disorders. This trend is providing scientific bases for personalized medicines but also new, important questions linked to the basic biochemistry field.

Ceramide transport protein, or CERT, moves the waxy lipids known as ceramides in cells for the synthesis of sphingomyelin, a membrane lipid that is ubiquitous in mammalian cells. In 2007, researchers found that CERT is functionally repressed by multiple phosphorylations of a serine-repeat motif, or SRM, in CERT. At the time, scientists regarded this finding as pure biochemistry of a protein.

However, a decade later, large-scale human genetic studies on intellectual disabilities and mental development disorders, or ID/MD, showed that missense mutations in or near the CERT SRM-encoding regions are associated with a type of autosomal dominant hereditary ID/MD. The dominant inheritance was in line with a prediction from the previous biochemical study that loss of hyperphosphorylation of the SRM renders CERT abnormally active.

Our confirmed this prediction by demonstrating that substitution of a serine residue in the SRM with other residues similar to variants found in ID/MD patients results in dysregulation of CERT in cultured cells. Nonetheless, several ID/MD-associated missense mutations that occurred in the CERT gene CERT1 also are mapped outside the SRM. This riddle was answered by showing that a non-SRM variant also compromises the SRM hyperphosphorylation, thereby abnormally activating CERT.

Moreover, cell biological analysis showed that abnormally activated CERT mutants exhibit an aberrant punctate distribution in cells, suggesting that the subcellular distribution pattern is applicable as a diagnostic tool to assess whether a CERT1 variant is an abnormally activated type that may cause ID/MD, although the precise identity of the puncta structure remains undetermined.

Advanced  human genetics studies have shown that missense mutations in the CERT1 gene encoding the ceramide <em>transport protein </em>CERT are associated with certain intellectual  disabilities and mental development disorders. Recent studies in the Hanada lab  showed that ID/MD-associated CERT variants are defective in the serine-repeat  motif phosphorylation-dependent repression. In this diagram, for simplicity, CERT  is illustrated as a monomer, although it forms oligomers in cells.
Kentaro Hanada
Advanced human genetics studies have shown that missense mutations in the CERT1 gene encoding the ceramide transport protein CERT are associated with certain intellectual disabilities and mental development disorders. Recent studies in the Hanada lab showed that ID/MD-associated CERT variants are defective in the serine-repeat motif phosphorylation-dependent repression. In this diagram, for simplicity, CERT is illustrated as a monomer, although it forms oligomers in cells.

Want more lipid research news?

Check out , a curated collection of hot picks from the world of lipid research, brought to you by .

Enjoy reading 91ÑÇÉ«´«Ã½ Today?

Become a member to receive the print edition four times a year and the digital edition weekly.

Learn more
Kentaro Hanada
Kentaro Hanada

Kentaro Hanada is a senior researcher in the quality assurance, radiation safety and information management department of the National Institute of Infectious Diseases in Japan, where he is also former director of the biochemistry and cell biology department and an emeritus officer.

Get the latest from 91ÑÇÉ«´«Ã½ Today

Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.

Latest in Science

Science highlights or most popular articles

Of genes, chromosomes and oratorios
Profile

Of genes, chromosomes and oratorios

Jan. 1, 2025

Jenny Graves has spent her life mapping genes and comparing genomes. Now she’s created a musical opus about evolution of life on this planet — bringing the same drive and experimentalism she brought to the study of marsupial chromosomes.

Ubiquitination by TRIM13: An ingredient contributing to diet-induced atherosclerosis
Journal News

Ubiquitination by TRIM13: An ingredient contributing to diet-induced atherosclerosis

Dec. 31, 2024

Researchers help unravel the molecular mechanism behind plaque formation in cardiovascular disease.

When ribosomes go rogue
News

When ribosomes go rogue

Dec. 29, 2024

 Unusual variations in the cellular protein factory can skew development, help cancer spread and more. But ribosome variety may also play biological roles, scientists say.

New discovery enables gene therapy for muscular dystrophies, other disorders
News

New discovery enables gene therapy for muscular dystrophies, other disorders

Dec. 28, 2024

At the University of Rochester, researchers find that RNA-based technology facilitates effective use for difficult-to-treat, large-gene diseases.

From the journals: JBC
Journal News

From the journals: JBC

Dec. 27, 2024

Huntington protein interactions affect aggregation. Intrinsically disordered protein forms a scaffold. From unknown protein to curbing cancer growth. Read about recent JBC papers on these topics.

An inclusive solar eclipse — with outreach
Essay

An inclusive solar eclipse — with outreach

Dec. 26, 2024

Traveling more than 150 miles with a group of neurodivergent students to have them witness a rare orbital alignment. and also teach the public about it, requires some strategic planning.